The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tezikov Yu.V.

Samara State Medical University

Lipatov I.S.

Samara State Medical University

Yakusheva A.O.

Samara State Medical University

Novel coronavirus infection and pregnancy: features of the course of gestation and the possibility of predicting the progression of COVID-19 severity in pregnant women

Authors:

Tezikov Yu.V., Lipatov I.S., Yakusheva A.O.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2023;23(1): 30‑38

DOI: 10.17116/rosakush20232301130

Read: 2755 times

Download PDF (RU)
Contact the author
Table of contents

NOVEL CORONAVIRUS INFECTION AND PREGNANCY: FEATURES OF THE COURSE OF GESTATION AND THE POSSIBILITY OF PREDICTING THE PROGRESSION OF COVID-19 SEVERITY IN PREGNANT WOMEN
NOVEL CORONAVIRUS INFECTION AND PREGNANCY: FEATURES OF THE COURSE OF GESTATION AND THE POSSIBILITY OF PREDICTING THE PROGRESSION OF COVID-19 SEVERITY IN PREGNANT WOMEN

To cite this article:

Tezikov YuV, Lipatov IS, Yakusheva AO. Novel coronavirus infection and pregnancy: features of the course of gestation and the possibility of predicting the progression of COVID-19 severity in pregnant women. Russian Bulletin of Obstetrician-Gynecologist. 2023;23(1):30‑38. (In Russ.)
https://doi.org/10.17116/rosakush20232301130

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Pecu­liarities of placental microRNA expression in patients with preeclampsia and fetal growth restriction. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):14-25
Changes in the type of psychological component of the gestational domi­nant in pregnant women in the third trimester after completing the peri­natal preparation program. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):66-71
Sexual function of women during pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):112-117
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
Local cyto­kine profile of the endo­metrium in patients with repeated implantation failures and its pharmacological correction by the secretome of peri­pheral blood mono­nuclear cells. Russian Journal of Human Reproduction. 2024;(5):46-54
Immu­nological aspe­cts of reccurent pregnancy loss. Russian Journal of Human Reproduction. 2024;(5):64-71
Loca­lization features of FAP-positive acti­vated stro­mal cells in fibrosis in patients with new coro­navirus infe­ction COVID-19. Russian Journal of Archive of Pathology. 2024;(6):5-14
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Lapa­roscopic appe­ndectomy for appe­ndiceal muco­cele in a patient with COVID-19. Endo­scopic Surgery. 2024;(6):41-45
Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medi­cine. 2024;(12):114-121
Abstract:

The authors analyzed the literature data on the possibility of timely diagnosis and prognosis of COVID-19 progression and development of life-threatening complications during gestation. Pregnant women are at high risk for a severe course of the disease, which is inherent in the prerequisites of gestational adaptation mechanisms. This review presents various aspects of COVID-19 and pregnancy, ranging from the etiopathogenesis and clinical features of the course of the disease in pregnant women to highly informative laboratory methods for predicting the severity of COVID-19. The studies presented demonstrate the scientific and practical interest in developing and implementing pathogenetically valid markers to stratify pregnant women at risk for COVID-19 progression and adverse gestational, perinatal, and somatic outcomes. The current knowledge and practice are insufficient for their large-scale application to effectively address the challenges of timely diagnosis of COVID-19 severity and the prognosis of life-threatening complications, prolonged course of disease, or postconceptional syndrome, which is essential to maintain quality of life, fully develop the biological system of mother and newborn, and preserve reproductive potential.

Keywords:

pregnancy
COVID-19
new coronavirus infection
severity prediction
early diagnosis
severity of COVID-19 course

Authors:

Tezikov Yu.V.

Samara State Medical University

Lipatov I.S.

Samara State Medical University

Yakusheva A.O.

Samara State Medical University

Received:

28.03.2022

Accepted:

26.04.2022

Close metadata

References:

  1. Subbaraman N. Pregnancy and COVID: what the data say. Nature. 2021;7849:591:193-195.  https://doi.org/10.1038/d41586-021-00578-y
  2. Papapanou M, Papaioannou M, Petta A, Routsi E, Farmaki M, Vlahos N, Siristatidis C. Maternal and neonatal characteristics and outcomes of COVID19 in pregnancy: an overview of systematic reviews. Int J Environ Res Public Health. 2021;18:2:596.  https://doi.org/10.3390/ijerph18020596
  3. Shchelkanov MYu, Popova AYu, Dedkov VG, Akimkin VG, Maleev VV. History of investigation and current classification of coronaviruses (Nidovirales: Coronaviridae). Infektsiya i immunitet. 2020;10:2:221-246. (In Russ.). https://doi.org/10.15789/2220-7619-HOI-1412
  4. Babarinsa IA, Okunoye GO, Odukoya O. Severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV) infections in pregnancy — An overview. Eur J Obstet Gynecol Reprod Biol. 2021;263:171-175.  https://doi.org/10.1016/j.ejogrb.2021.06.020
  5. Nikiforov VV, Suranova TG, Chernobrovkina TYa, Yankovskaya YaD, Burova SV. Novel coronavirus infection (COVID-19): clinical and epidemiological aspects. Arhiv# vnutrennei meditsiny (Internal Medicine Archive). 2020;10:2:87-93. (In Russ.). https://doi.org/10.20514/2226-6704-2020-10-2-87-93
  6. Makatsariya AD, Slukhanchuk EV, Bitsadze VO, Khizroeva DKh, Tretyakova MV, Makatsariya NA, Akin’shina SV, Shkoda AS, Pankrat’eva LL, Di Rentso DK, Ritstso D, Grigor’eva KN, Tsibizova VI, Gri Zh-K, Elalami I. Neutrophil extracellular traps: a role in inflammation and dysregulated hemostasis as well as in patients with COVID-19 and severe obstetric pathology. Akusherstvo, ginekologia i reproduktsiya. 2021;15:4:335-350. (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2021.238
  7. Jafari M, Pormohammad A, Sheikh Neshin SA, Ghorbani S, Bose D. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol. 2021;31:5:1-16.  https://doi.org/10.1002/rmv.2208
  8. Dinah V, Parums S. Maternal SARS-CoV-2 infection and pregnancy outcomes from current global study data. Medical Science Monitor. 2021;27:e933831-1.  https://doi.org/10.12659/MSM.933831
  9. Nayak AH, Kapote DS, Fonseca M, Chavan N, Mayekar R, Sarmalkar M, Bawa A. Impact of the coronavirus infection in pregnancy: a preliminary study of 141 patients. J Obstet Gynaecol India. 2020;70:4:256-261.  https://doi.org/10.1007/s13224-020-01335-3
  10. Obstetrics: National guide. Ed. Savel’eva G.M., Sukhikh G.T., Serov V.N., Radzinskii V.E. M.: GEOTAR-Media Publ; 2018;1088. (In Russ.).
  11. Bano S, Agrawal A, Asnani M, Das V, Singh R, Pandey A. Correlation of insulin resistance in pregnancy with obstetric outcome. J Obstet Gynaecol India. 2021;71:5:495-500.  https://doi.org/10.1007/s13224-021-01426-9
  12. Organization of medical care for pregnant women, women in labor, maternity hospitals and newborns with a new coronavirus infection COVID-19. Methodological recommendations. The Ministry of Health of Russia. Version 5. 12.2021. 135. (In Russ.).
  13. Allotey J, Stallings E, Bonet M. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. Obstetric Anesthesia Digest. 2021;41:2:81-82.  https://doi.org/10.1097/01.aoa.0000744128.44930.48
  14. Ackerman CM, Nguyen JL, Ambati S. Clinical and pregnancy outcomes of coronavirus disease 2019 among hospitalized pregnant women in the United States. Open Forum Infect Dis. 2022;9:2:ofab429. https://doi.org/10.1093/ofid/ofab429
  15. Temporary methodological recommendations. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 14 from 27.12.21. (In Russ.).
  16. RCOG. Royal College of Obstetricians & Gynaecologists. Coronavirus (COVID-19) infection in pregnancy. Version 14: Published Wednesday 25 August 2021. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/coronavirus-pregnancy/
  17. Petrova UL, Shmakov RG. New coronavirus infection 2019 and pregnancy: what do we know? Akusherstvo i ginekologiya. 2022;2:4-11. (In Russ.). https://doi.org/10.18565/aig.2022.2.4-11
  18. Diriba K, Awulachew E, Getu E. The effect of coronavirus infection (SARSCoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta- analysis. Eur J Med Res. 2020;25:39.  https://doi.org/10.1186/s40001-020-00439-w
  19. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020;395:10226:809-815.  https://doi.org/10.1016/S0140-6736(20)30360-3
  20. Shah PS, Diambomba Y, Acharya G, Morris SK, Bitnun A. Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates. Acta Obstet Gynecol Scand. 2020;99:5:565-568. 
  21. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:2:271-280.e8.  https://doi.org/10.1016/j.cell.2020.02.052
  22. Favre G, Mazzetti S, Gengler C, Bertelli C, Schneider J, Laubscher B, Capoccia R, Pakniyat F, Ben Jazia I, Eggel-Hort B, de Leval L, Pomar L, Greub G, Baud D, Giannoni E. Decreased Fetal Movements: A Sign of Placental SARS-CoV-2 infection with perinatal brain injury. Viruses. 2021;13:12:2517. https://doi.org/10.3390/v13122517
  23. Shchegolev AI, Tumanova UN, Serov VN. Placental lesions in pregnant women with SARS-CoV-2 infection. Akusherstvo i ginekologiya. 2020; 12:44-52. (In Russ.). https://doi.org/10.18565/aig.2020.12.44-52
  24. Song D, Prahl M, Gaw SL, Narasimhan S, Rai D, Huang A. Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: Prospective cohort study. medRxiv. Preprint. https://doi.org/10.1101/2021.05.01.21255871
  25. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395:10234:1417-1418. https://doi.org/10.1016/S0140-6736(20)30937-5
  26. Chkhaidze IZ, Lioznov DA, Petrishchev NN, Niauri DA. Systemic endotheliitis in a new coronavirus infection COVID-19: gender and perinatal risks. Regionarnoe krovoobrashchenie i mikrotsirkulyatsiya. 2021;20:4:4-13. (In Russ.). https://doi.org/10.24884/1682-6655-2021-20-4-4-13
  27. Farinacci M, Krahn T, Dinh W. Circulating endothelial cells as biomarker for cardiovascular diseases. Research and practice in thrombosis and haemostasis. 2018;3:1:49-58.  https://doi.org/10.1002/rth2.12158
  28. Guervilly Ch, Burtey S, Sabatier F, Cauchois R, Lano G, Abdili E. Circulating endothelial cells as a marker of endothelial injury in severe COVID-19. J Infect Dis. 2020;222:11:1789-1793. https://doi.org/10.1093/infdis/jiaa528
  29. Lipatov IS, Tezikov YuV, Kovyazina IO. Endothelial-hemostasiological dysfunction as a reflection of the severity of SARS-COV-2 infection in pregnant women. Akusherstvo i ginekologiya. Tezisy III Nacional’nogo Kongressa s mezhdunarodnym uchastiem «LABRiN-2021. Infektsii. God s COVID-19». 2021;3:15. (In Russ.).
  30. Willems LH, Nagy M, Ten Cate H, Spronk HMH, Groh LA, Leentjens J, Janssen NAF, Netea MG, Thijssen DHJ, Hannink G, van Petersen AS, Warlé MC. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb Res. 2022;209:106-114.  https://doi.org/10.1016/j.thromres.2021.11.027
  31. Gregoriano C, Damm D, Kutz A, Koch D, Wolfisberg S, Haubitz S, Conen A, Bernasconi L, Hammerer-Lercher A, Fux CA, Mueller B, Schuetz P. Association of endothelial activation assessed through endothelin-I precursor peptide measurement with mortality in COVID-19 patients: an observational analysis. Respir Res. 2021;22:1:148.  https://doi.org/10.1186/s12931-021-01742-8
  32. Ruzhentsova T, Chukhliaev P, Khavkina D, Garbuzov AA, Akimkin VG, Zhundrikova VI, Tivanova EV. The role of endothelin-I in cardiovascular disease in patients with COVID-19.  https://doi.org/10.2139/ssrn.3831110
  33. Gao Y-D, Ding M, Dong X. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76:428-455.  https://doi.org/10.1111/all.14657
  34. Lopez-Delgado JC, Rovira A, Esteve F. Thrombocytopenia as a mortality risk factor in acute respiratory failure in H₁N₁ influenza. Swiss Med Wkly. 2013;143:w13788. https://doi.org/10.4414/smw.2013.13788
  35. Nori W, Hameed B, Thamir A, Fadhil A. COVID-19 in pregnancy: implication on platelets and blood indices. Revista Brasileira de Ginecologia eObstetrícia. 2021;43:08:595-599.  https://doi.org/10.1055/s-0041-1733912
  36. Shah A, Frost JN, Aaron L, Donovan K, Drakesmith H, Collaborators (2020). Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19. Critical Care. 2020; 24:1:320.  https://doi.org/10.1186/s13054-020-03051-w
  37. Kronstein-Wiedemann R, Stadtmüller M, Traikov S. SARS-CoV-2 infects red blood cell progenitors and dysregulates hemoglobin and iron metabolism. Stem Cell Rev Report. 2022;1-13.  https://doi.org/10.1007/s12015-021-10322-8
  38. Gromova OA, Torshin IYu, Shapovalova YuO, Kurtser MA, Chuchalin AG. COVID-19 and iron deficiency anemia: the relationship of pathogenesis and therapy. Akusherstvo, ginekologiya i reproduktsiya. 2020;14:5:644-655 (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.179
  39. Cappanera S, Palumbo M, Kwan SH. When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick score to recognize it. J Clin Med. 2021;10:2-297.  https://doi.org/10.3390/jcm10020297
  40. Tkachenko OYu, Pervakova MYu, Lapin SV, Mazing AV, Moshnikova AN, Kuznetsova DA. Forecasting the flow of viral pneumonia at COVID-19 using the cytokine storm scale. Therapiya. 2021;6:42-50.  https://doi.org/10.18565/therapy.2021.6.42-50
  41. Tan Y, Tang F. SARS-CoV-2-mediated immune system activation and potential application in immunotherapy. Med Res Rev. 2021;41:1167-1194. https://doi.org/10.1002/med.21756
  42. Klypa TV, Bychinin MV, Mandel’ IA, Andreichenko SA, Minets AI, Kolyshkina NA, Troitskii AV. Clinical characteristics of patients admitted to an ICU with COVID-19. Predictors of the severe disease. Klinicheskaya praktika. 2020;11:2:6-20.  https://doi.org/10.17816/clinpract34182
  43. Pujani M, Raychaudhuri S, Singh M. An analysis of hematological, coagulation and biochemical markers in COVID-19 disease and their association with clinical severity and mortality: an Indian outlook. Am J Blood Res. 2021;11:6:580-591. 
  44. Yi Li, Haitao Li, Chao Song, Rongli Lu, Yuhao Zhao, Fengyu Lin. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio. Dis Markers. 2021;11.  https://doi.org/10.1155/2021/6304189
  45. Ostrovskii VK, Mashchenko AV, Yakovenko DV, Makarov SV. The some blood parameters and leukocytic index of intoxication in evaluation of the severity and the determination of their prognosis of inflammatory, purulent and pyodestructive diseases. Klinicheskaya laboratornaya diagnostika. 2006;6:50-53. 
  46. Tezikov YuV, Lipatov IS, Kalinkina OB, Novoslugina EA. Evaluation of diagnostic informativeness of leukocyte indices in pregnant women with COVID-19. Akusherstvo i ginekologiya. Tezisy. Nacional’nogo kongressa s mezhdunarodnym uchastiem «LABRiN-2021. Infekcii. God s COVID-19». 2021;3-25. (In Russ.).
  47. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Int Med. 2020;180:7:934-943.  https://doi.org/10.1001/jamainternmed.2020.0994
  48. Lippi G, Favaloro EJ. D-dimer is associated with severity of coronavirus disease. 2019: A Pooled Analysis. J Thromb Haemost. 2020;120:5:876-878.  https://doi.org/10.1055/s-0040-1709650
  49. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:4:844-847.  https://doi.org/10.1111/jth.14768
  50. Deng Y, Liu W, Liu K, Fang YY, Shang J, Zhou L. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chinese Med J. 2020;133:11:1261-1267. https://doi.org/10.1097/CM9.0000000000000824
  51. Liu T, Zhang J, Yang Y, Ma H, Li Z, Zhang J. The role of interleukin-6 in monitoring severe case of coronavirus disease 2019. EMBO Mol Med. 2020;7:12:7:e12421. https://doi.org/10.15252/emmm.202012421
  52. Polushin YuS, Shlyk IV, Gavrilova EG, Parshin EV, Ginzburg AM. The role of ferritin in assessing the severity of COVID-19. Vestnik anesteziologii i reanimatologii. 2021;18:4:20-28. (In Russ.). https://doi.org/10.21292/2078-5658-2021-18-4-20-28
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.